- Home
- KIND vs BBNX Comparison
KIND vs BBNX Comparison
Compare KIND & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- BBNX
- Stock Information
- Founded
- KIND 2011
- BBNX 2015
- Country
- KIND United States
- BBNX United States
- Employees
- KIND N/A
- BBNX N/A
- Industry
- KIND Computer Software: Programming Data Processing
- BBNX Medical/Dental Instruments
- Sector
- KIND Technology
- BBNX Health Care
- Exchange
- KIND Nasdaq
- BBNX Nasdaq
- Market Cap
- KIND 608.3M
- BBNX 578.8M
- IPO Year
- KIND N/A
- BBNX 2025
- Fundamental
- Price
- KIND $1.88
- BBNX $14.84
- Analyst Decision
- KIND Buy
- BBNX Strong Buy
- Analyst Count
- KIND 4
- BBNX 10
- Target Price
- KIND $2.56
- BBNX $25.20
- AVG Volume (30 Days)
- KIND 2.3M
- BBNX 434.1K
- Earning Date
- KIND 08-07-2025
- BBNX 07-29-2025
- Dividend Yield
- KIND N/A
- BBNX N/A
- EPS Growth
- KIND N/A
- BBNX N/A
- EPS
- KIND N/A
- BBNX N/A
- Revenue
- KIND $248,306,000.00
- BBNX $69,830,000.00
- Revenue This Year
- KIND $1.66
- BBNX $32.71
- Revenue Next Year
- KIND $10.87
- BBNX $37.37
- P/E Ratio
- KIND N/A
- BBNX N/A
- Revenue Growth
- KIND 12.01
- BBNX 38911.17
- 52 Week Low
- KIND $1.32
- BBNX $8.89
- 52 Week High
- KIND $3.00
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- KIND 60.19
- BBNX N/A
- Support Level
- KIND $1.63
- BBNX N/A
- Resistance Level
- KIND $2.50
- BBNX N/A
- Average True Range (ATR)
- KIND 0.13
- BBNX 0.00
- MACD
- KIND 0.02
- BBNX 0.00
- Stochastic Oscillator
- KIND 31.11
- BBNX 0.00
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.